http://orcid.org/0000-0002-4314-1407
About the Authors
- Mangala M. Soundarapandian
-
Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing – review & editing
* E-mail: msoundar@alnylam.com (MMS); deleon@email.chop.edu (DDDL)
Affiliation Alnylam Pharmaceuticals, Cambridge, Massachusetts, United States of America
- Christine A. Juliana
-
Roles Data curation, Formal analysis, Writing – original draft
Affiliation Division of Endocrinology and Diabetes, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America
- Jinghua Chai
-
Roles Investigation
Affiliation Division of Endocrinology and Diabetes, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America
- Patrick A. Haslett
-
Roles Conceptualization, Writing – review & editing
Affiliation Alnylam Pharmaceuticals, Cambridge, Massachusetts, United States of America
- Kevin Fitzgerald
-
Roles Conceptualization, Writing – review & editing
Affiliation Alnylam Pharmaceuticals, Cambridge, Massachusetts, United States of America
- Diva D. De León
-
Roles Conceptualization, Methodology, Project administration, Supervision, Writing – review & editing
* E-mail: msoundar@alnylam.com (MMS); deleon@email.chop.edu (DDDL)
Affiliations Division of Endocrinology and Diabetes, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America, Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
Competing Interests
MMS, PAH and KF work for Alnylam Pharamaceuticals; MMS, PAH and KF hold shares in Alnylam Pharmaceuticals stock; DDDL received funding from Alnylam Pharmaceuticals to conduct this study. We confirm that this does not alter our adherence to the PLOS ONE policies on sharing data and materials and have updated our Competing Interests statement.